Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Draft Canadian Module 1 Schema Version 2.1

The online consultation is now closed. The content found on this page is a snapshot of the live consultation as it was presented to the public and contains the content that was open for submissions during the consultation period.

Health Canada is pleased to announce the release of the draft Canadian Module 1 Schema Version 2.1 for a 30-day consultation period. Once final, it will replace the 2004 Canadian Document Type Definition (DTD) Version 1.0 as per the following schedule:

  • To accept regulatory activities built with the revised Canadian Module 1 Schema by end of September 2012.
  • As of March 21, 2013, Health Canada will no longer be accepting regulatory activities built with the old Canadian Module 1 DTD.

The Canadian Module 1 Schema Version 2.1 is meant to accompany the Guidance for Industry: Creation of the Canadian Module 1 Backbone for the implementation of electronic regulatory activities that are compliant with the International Conference on Harmonization (ICH) M2 electronic Common Technical Document (eCTD) specifications.

How to Get Involved

This consultation is open for comment starting March 30, 2012 until April 30, 2012. Please select and read through the link below titled "consultation document". Once read please submit your comments via email, fax or by mail to:

  • eReview@hc-sc.gc.ca
  • Submission and Information Policy Division (SIPD)
    Therapeutic Products Directorate
    Health Canada
    Finance Building 2,
    Address Locator 0201A1
    101 Tunney's Pasture Driveway
    Ottawa, Ontario
    K1A 0K9
  • Telephone: 613-941-7281
    Fax: 613-941-0825

Consultation Document

Interested parties are encouraged to provide comments and suggestions by April 30, 2012.

Reporting to Canadians

Health Canada will make the results of this consultation available on this Web site.

If you have any questions, contact us at eReview.